US 11542261
Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors
granted A61KA61K31/496
Quick answer
US patent 11542261 (Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/496